ArticleFrontiers in nephrology2026
Improvement in peritoneal dialysis exit-site infection rates in an integrated health care system in the United States.
Article in Frontiers in nephrology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Exit-site infections (ESIs) are a significant complication of peritoneal dialysis (PD) due to their potential to progress to peritonitis, leading to higher rates of morbidity, mortality, and PD dropout. ESI rates and trends have not been generally recorded or reported by established registries. To address this gap, we studied data from ten Kaiser Permanente Southern California (KPSC) hospitals over the last decade to report yearly PD ESI rates and examine trends over time. Methods: This is a historical cohort study using data provided by the Renal Registry of Southern California Permanente Medical Group (SCPMG) for ten KPSC hospitals. Each hospital provided quarterly data from 2014-2023 with number of patients and ESI rate, reported as episodes per 100 patient-months. We modeled quarterly ESI rates across all centers (2014-2023) using a Tweedie generalized linear mixed model with calendar year and program size as fixed effects, accounting for repeated measures within center. Results: The overall mean ESI rate across the study period was 0.86 episodes per 100 patient-months (95% CI: 0.68-1.05). The observed mean ESI rate was 1.26 (95% CI: 0.98-1.60) episodes per 100 patient-months in 2014, compared with 0.72 (95% CI: 0.42-1.07) in 2023. Each additional calendar year was associated with a 6.4% relative decrease in ESI rate (rate ratio [RR] 0.94, 95% CI 0.89-0.99, Conclusion: We found a significant decline in ESI rates across ten KPSC hospitals from 2014 to 2023. This decline was not explained by growth in program size, suggesting that other factors-such as evolving infection prevention practices, staff training, or care coordination-may have contributed, though our data do not permit us to test these mechanisms directly. We encourage prospective or mechanism-specific studies to explore which factors are driving these improvements.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.